Home NDC 64380-781 Oxybutynin Chloride
Product NDC 64380-781
11-digit product format 643800781
Labeler code 64380
Product ID 64380-781_2994f946-dd30-4521-ab55-ee30ba1a6d5f
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Oxybutynin Chloride
Dosage form TABLET
Route ORAL
Labeler Strides Pharma Science Limited
Application ANDA208165
Marketing category ANDA
Marketing start 2024-12-20
Substance OXYBUTYNIN CHLORIDE
Active strength 5 mg/1
Pharmacologic classes Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 36 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A208165-001 OXYBUTYNIN CHLORIDE OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A208165-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL 2020-12-17 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL 2020-12-17 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL 2020-12-17 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL 2020-12-17 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL 2020-12-17 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 5aa47cf7b7d7…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL 2020-12-17 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A208165-001 OXYBUTYNIN CHLORIDE 5MG TABLET / ORAL AB 2020-12-17 a50c72e98297…
Observed Orange Book normalized TE history# Additional Listing Data#
Finished product Yes
Brand name base Oxybutynin Chloride
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength OXYBUTYNIN CHLORIDE 5 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination L9F3D9RENQ Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 863664 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# NDC, Effective, Related label table NDC Effective Related label 64380-781-03 2024-12-20 OXYBUTYNIN CHLORIDE TABLETS, USP 64380-781-03 2024-12-20 OXYBUTYNIN CHLORIDE TABLETS, USP 64380-781-05 2024-12-20 OXYBUTYNIN CHLORIDE TABLETS, USP 64380-781-05 2024-12-20 OXYBUTYNIN CHLORIDE TABLETS, USP 64380-781-06 2024-12-20 OXYBUTYNIN CHLORIDE TABLETS, USP 64380-781-06 2024-12-20 OXYBUTYNIN CHLORIDE TABLETS, USP 64380-781-07 2024-12-20 OXYBUTYNIN CHLORIDE TABLETS, USP 64380-781-07 2024-12-20 OXYBUTYNIN CHLORIDE TABLETS, USP 64380-781-08 2024-12-20 OXYBUTYNIN CHLORIDE TABLETS, USP 64380-781-08 2024-12-20 OXYBUTYNIN CHLORIDE TABLETS, USP 64380-781-03 2024-01-30 OXYBUTYNIN CHLORIDE TABLETS, USP 64380-781-03 2024-01-30 OXYBUTYNIN CHLORIDE TABLETS, USP 64380-781-05 2024-01-30 OXYBUTYNIN CHLORIDE TABLETS, USP 64380-781-05 2024-01-30 OXYBUTYNIN CHLORIDE TABLETS, USP 64380-781-06 2024-01-30 OXYBUTYNIN CHLORIDE TABLETS, USP 64380-781-06 2024-01-30 OXYBUTYNIN CHLORIDE TABLETS, USP 64380-781-07 2024-01-30 OXYBUTYNIN CHLORIDE TABLETS, USP 64380-781-07 2024-01-30 OXYBUTYNIN CHLORIDE TABLETS, USP 64380-781-08 2024-01-30 OXYBUTYNIN CHLORIDE TABLETS, USP 64380-781-08 2024-01-30 OXYBUTYNIN CHLORIDE TABLETS, USP
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 64380-781-03 Oxybutynin Chloride 60 in 1 BOTTLE TABLET 60 5 64380-781-05 Oxybutynin Chloride 90 in 1 BOTTLE TABLET 90 5 64380-781-06 Oxybutynin Chloride 100 in 1 BOTTLE TABLET 100 5 64380-781-07 Oxybutynin Chloride 500 in 1 BOTTLE TABLET 500 5 64380-781-08 Oxybutynin Chloride 1000 in 1 BOTTLE TABLET 1000 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 64380-781 OXYBUTYNIN CHLORIDE TABLET [STRIDES PHARMA SCIENCE LIMITED] 4 Current NDC, Legacy NDC, 5 package rows 20241222_ac10c7b7-d0cb-4068-93e2-c0e51f15866e.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 5 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 64380-781-03 64380078103 60 TABLET in 1 BOTTLE (64380-781-03) 60 tablet 2024-12-20 0000-00-00 No No Current 64380-781-05 64380078105 90 TABLET in 1 BOTTLE (64380-781-05) 90 tablet 2024-12-20 0000-00-00 No No Current 64380-781-06 64380078106 100 TABLET in 1 BOTTLE (64380-781-06) 100 tablet 2024-12-20 0000-00-00 No No Current 64380-781-07 64380078107 500 TABLET in 1 BOTTLE (64380-781-07) 500 tablet 2024-12-20 0000-00-00 No No Current 64380-781-08 64380078108 1000 TABLET in 1 BOTTLE (64380-781-08) 1000 tablet 2024-12-20 0000-00-00 No No Current